Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
US stocks moving | Moderna continues to rise nearly 7% pre-market, advancing multiple early-stage studies related to hantavirus vaccines

US stocks moving | Moderna continues to rise nearly 7% pre-market, advancing multiple early-stage studies related to hantavirus vaccines

格隆汇格隆汇2026/05/11 08:30
Show original
```htmlGlonghui May 11|Moderna (MRNA.US) continued to rise nearly 7% in pre-market trading, reaching $58.1. Last Friday, the stock closed up nearly 12%. In terms of news, Moderna disclosed that it is advancing multiple early-stage studies related to the hantavirus vaccine. In a statement, the company said it had previously conducted early-stage vaccine research targeting hantavirus with the U.S. Army Medical Research Institute of Infectious Diseases. In addition, the company is cooperating with the Vaccine Innovation Center at Korea University College of Medicine to develop a potential immune protocol. The related research started before the recent outbreak on the ‘Hondius’ cruise ship.```
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!